Compare YieldMax COIN Option Income Strategy ETF (CONY) vs Medpace Holdings Inc (MEDP) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
YieldMax COIN Option Income Strategy ETF vs Medpace Holdings Inc — how do they compare? YieldMax COIN Option Income Strategy ETF trades at $19.04 (market cap $370.88M), while Medpace Holdings Inc trades at $612.05 (market cap $16.82B). The key difference: Medpace Holdings Inc is far larger — about 45.4× YieldMax COIN Option Income Strategy ETF's market cap, and Medpace Holdings Inc is trading nearer its 52-week high, YieldMax COIN Option Income Strategy ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold YieldMax COIN Option Income Strategy ETF for 41 Days and Medpace Holdings Inc for 14 Days on average.
| CONY | MEDP | |
|---|---|---|
Market Cap | $370.88M | $16.82B |
Volume | 595,904 | 223,093 |
Sector | Income / Options Overlay | Health |
52-Week High | $76.50 | $630.19 |
52-Week Low | $17.73 | $393.42 |
Typical Hold Time | 41 Days | 14 Days |
Enterprise Value | — | $16.44B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
CONY trades at $19.04, down 0.63% on the day, with a bearish technical signal from moving averages but bullish oscillators like RSI indicating potential oversold conditions. The ETF has experienced significant price erosion year-to-date, with a 51.3% decline noted in recent analysis, despite offering high distribution yields. Recent news highlights weekly dividend announcements and regulatory impacts on crypto-related stocks.
The outlook remains challenging due to structural NAV decay and full downside exposure to COIN. While the shift to a call spread strategy offers partial upside participation, the fund's high-risk profile and regulatory uncertainties present substantial headwinds for investors seeking stable returns.
MEDP trades at $612.05, up 1.29% today, near its consensus price target of $620.44. The stock shows strong profitability with a 17.67% net margin and has beaten earnings estimates for the last three quarters. Technical indicators are neutral overall, with support at $595 and resistance at $612. Recent news highlights CEO stock sales and institutional position changes, while the company prepares to report Q3 2026 results on October 21.
Outlook remains positive given consistent earnings beats and projected revenue growth to $2.8B in 2026. Risks include high valuation multiples (P/E 35.41) and insider selling. Analyst consensus is cautious with 79% hold ratings, suggesting limited near-term upside but solid fundamental support for long-term holders.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About YieldMax COIN Option Income Strategy ETF
CONY is an actively managed ETF that seeks to generate weekly income by selling call options on Coinbase (COIN) stock. It aims to provide high yield while maintaining exposure to the price movements of the crypto exchange.
Read more on CONY →About Medpace Holdings Inc
Medpace Holdings, Inc. is a full-service clinical contract research organization (CRO) that provides comprehensive and scientifically-driven clinical development services to the biotechnology, pharmaceutical, and medical device industries. The company specializes in conducting global clinical trials for new drug and medical device approvals. Medpace's model emphasizes therapeutic expertise and a highly integrated approach to accelerate the clinical development process for its clients.
Read more on MEDP →
